Latest News

US monkeypox response: 31% of cases among Black persons, vaccine distribution equity concerns persist.

ADAP Advocacy Association Fireside Chats resume with discussions on utilization management and EHE progress.

2020 CDC HIV surveillance reveals COVID-19's impact on HIV prevention and testing with decreased diagnoses and increased deaths.

Family support predicts treatment success; policy must address intimate partner violence and health outcomes.

CANN announces 2022 organizational changes including rebranding and launching the 340B Action Center.

New CANN leadership reflects on mentorship and maintaining advocacy legacy following Bill Arnold's passing.

Global Fund report shows COVID-19 reduced HIV/HCV program efficacy while South Africa tripled ART coverage.

COVID-19 strains public health efforts addressing HIV outbreaks, diverting resources from the domestic epidemic.

Study explores social-spatial networks and HIV/HCV diagnosis rates among homeless and injection drug users.

CANN roundtable discusses pandemic's impacts on HIV, HCV, STI, and SUD programs and funding weaknesses.

COVID-19 disrupts STI surveillance as staff redeployment, testing shortages, and clinic closures create gaps.

Analysis of Kanawha County HIV outbreak highlighting substance use, rural healthcare gaps, and pandemic impact.

Housing instability increases HIV/HCV acquisition by 55-65%; housing investments outpace health interventions.

Assesses pandemic's ongoing impact on HIV, HCV, and SUD surveillance and care with vaccine rollout.

Family courts and child welfare systems miss opportunities to address health needs and social determinants.

Evaluates pandemic's impacts on HIV, HCV, and SUD services including testing disruptions and telehealth expansion.